William Blair analyst Andy Hsieh initiated coverage of BioAge Labs (BIOA) with a Market Perform rating.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIOA:
- Hold Rating for BioAge Labs, Inc.: Balancing Innovative Potential with Competitive and Developmental Challenges
- BIOA Lawsuit Alert! Class Action Lawsuit Against BioAge Labs, Inc.
- Nine new option listings on February 12th
- BioAge Labs provides updates, terminates development of azelaprag
- Levi & Korsinsky LLP Notifies Shareholders of BioAge Labs, Inc.(BIOA) of a Class Action Lawsuit and an Upcoming Deadline